Advanced Health Intelligence (ASX:AHI) Research & Development: A$0.02 Mil (TTM As of Jun. 2024)


What is Advanced Health Intelligence Research & Development?

Advanced Health Intelligence ASX:AHI Research & Development is A$0.02 Mil as of Jun. 2024.

Research & Development is the aggregate amount of research and development expenses during the year. Advanced Health Intelligence's Research & Development for the six months ended in Jun. 2024 was A$0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Jun. 2024 was A$0.02 Mil.

Advanced Health Intelligence  (ASX:AHI) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Advanced Health Intelligence Research & Development Related Terms

Advanced Health Intelligence Research & Development Historical Data

* Premium members only.

The historical data trend for Advanced Health Intelligence's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Advanced Health Intelligence Research & Development Chart

Advanced Health Intelligence Annual Data
Trend Apr15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.22 0.00 0.16 0.03 0.00

Advanced Health Intelligence Semi-Annual Data
Apr15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.12 -0.10 0.02 0.00 0.00

Advanced Health Intelligence Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$0.02 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of A$0.02 Mil mean?
Advanced Health Intelligence (ASX:AHI) has a Research & Development of A$0.02 Mil as of Jun. 2024. Research and development expense is the total cost for research and development activities. View historical data on Advanced Health Intelligence and its competitors.
Is Advanced Health Intelligence's Research & Development too high?
Advanced Health Intelligence's current Research & Development is A$0.02 Mil.
How does Advanced Health Intelligence's Research & Development compare to PRST and LAAB?
Advanced Health Intelligence's Research & Development of A$0.02 Mil can be compared against companies in the Software industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Software company?
A good Research & Development depends on the Software industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Advanced Health Intelligence and its competitors. Advanced Health Intelligence's current Research & Development is A$0.02 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Advanced Health Intelligence stock overvalued right now?
Advanced Health Intelligence (ASX:AHI) has a current Research & Development of A$0.02 Mil. The current Research & Development is A$0.02 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Advanced Health Intelligence (ASX:AHI), the current Research & Development is A$0.02 Mil as of Jun. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Advanced Health Intelligence Business Description

Address 71-73 The Esplanade, Unit 5, South Perth, Perth, WA, AUS, 6151
Advanced Health Intelligence Ltd (AHI) is engaged in developing and delivering user-friendly biometric scans to render vital signs and health risk estimates to a smartphone. By leveraging the smartphone with purpose-built computer vision, machine learning models, and patented algorithms, AHI provides a private and secure way for individuals to perform biometric health-risk assessment and stratification. AHI's technology delivers simple-to-use, scalable, and cost-effective means to enable individuals to check, track and act towards better health outcomes. The combination of the patented and proprietary BodyScan dimensioning and composition capabilities and, FaceScan to return vital signs enables a unique health assessment capability made accessible anytime, anywhere through the smartphone.